Literature DB >> 10443521

Inhaled nitric oxide as a prophylactic treatment against reperfusion injury of the lung.

M Strüber1, W Harringer, M Ernst, T Morschheuser, M Hein, M Bund, A Haverich.   

Abstract

BACKGROUND: Inhaled Nitric Oxide (NO) has been found to be effective in clinical treatment of reperfusion injury after lung transplantation. This study was designed to determine a possible prophylactic role to reduce severe reperfusion injury.
METHODS: In 12 minipigs the left lung was selectively perfused with cold Euro-Collins solution. After 90 minutes of warm ischemia the lungs were reperfused and the contralateral pulmonary artery and main bronchus clamped. Hemodynamic and respiratory parameters were monitored for 7 hours. 6 animals were used as controls. 6 pigs formed the NO group and were ventilated continuously with 40 ppm nitric oxide (NO) starting 30 minutes prior to reperfusion.
RESULTS: In the control group right heart failure developed within 1.9 +/- 0.8 hours of reperfusion. Lung compliance was significantly reduced. A significant increase of pulmonary vascular resistance (PVR) was found. All animals of the NO group survived the reperfusion period of 7 hours. PVR was decreased compared to controls (p = 0.03). AaDO2 was lower, but not significantly different. The dynamic compliance of the lung was significantly higher (p = 0.007) in the NO group.
CONCLUSIONS: The prophylactic institution of inhaled NO reduces reperfusion injury of the lung. Short-term use of inhaled NO should be adopted as a prophylactic agent after transplantation of lungs preserved in Euro-Collins solution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443521     DOI: 10.1055/s-2007-1013137

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  6 in total

Review 1.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

2.  Formaldehyde exposure induces differentiation of regulatory T cells via the NFAT-mediated T cell receptor signalling pathway in Yucatan minipigs.

Authors:  Jeongsik Park; Goo-Hwa Kang; Youngkyu Kim; Ju Young Lee; Jeong Ah Song; Jeong Ho Hwang
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

Review 3.  Inhaled NO as a therapeutic agent.

Authors:  Kenneth D Bloch; Fumito Ichinose; Jesse D Roberts; Warren M Zapol
Journal:  Cardiovasc Res       Date:  2007-05-04       Impact factor: 10.787

Review 4.  Advanced technologies for the preservation of mammalian biospecimens.

Authors:  Haishui Huang; Xiaoming He; Martin L Yarmush
Journal:  Nat Biomed Eng       Date:  2021-08-23       Impact factor: 29.234

5.  Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites.

Authors:  Yasuko Nagasaka; Bernadette O Fernandez; Andrea U Steinbicker; Ester Spagnolli; Rajeev Malhotra; Donald B Bloch; Kenneth D Bloch; Warren M Zapol; Martin Feelisch
Journal:  Nitric Oxide       Date:  2018-08-13       Impact factor: 4.427

6.  What is the role of surfactant and inhaled nitric oxide in lung transplantation?

Authors:  Martin Strüber
Journal:  Crit Care       Date:  2002-05-09       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.